WLN: T6NJ CVQ

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 9 USDMF, 3 CEP/COS, 3 EU WC, 2 KDMF, 4 NDC API, 12 Listed Suppliers

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

FINISHED DOSAGE FORMULATIONS

100 FDF Dossiers, 60 FDA Orange Book, 16 Europe, 1 Canada, 2 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Evonik, 13 Rochem International Inc, 23 SPI Pharma, 2 Pharm-RX Chemical, 6 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 20 Kirsch Pharma, 1 Panvo Organics, 1 Cerata Pharmaceuticals LLP, 17 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 36 BASF, 1 Bioplus Life Sciences, 5 Cassava Pharma, 4 CD Formulation, 2 Clariant, 15 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 3 Gloria Interchem, 9 Ideal Cures, 4 Ingredion Pharma Solutions, 2 JJ Chemicals, 22 Kerry, 3 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 1 Nanjing Bold Chemical, 2 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 11 Pluviaendo, 3 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 35 Roquette, 17 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

105 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 46 Thickeners and Stabilizers, 46 Parenteral, 43 Solubilizers, 40 Controlled & Modified Release, 40 Taste Masking, 38 Direct Compression, 33 Granulation, 32 Topical, 29 Lubricants & Glidants, 29 Film Formers & Plasticizers, 28 Disintegrants & Superdisintegrants, 24 Chewable & Orodispersible Aids, 18 API Stability Enhancers, 17 Co-Processed Excipients, 14 Emulsifying Agents, 9 Empty Capsules, 9 Surfactant & Foaming Agents, 8 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

17 News #PharmaBuzz

17 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 11 Regulatory FDF Prices

MARKET PLACE

19 APIs, 1 Intermediates

PATENTS & EXCLUSIVITIES

24 Health Canada Patents

24 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 2 JP, 5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

WLN: T6NJ CVQ

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Roquette

filter Capability Reset all filters

filter Country Reset all filters

01

Roquette

LYCAGEL

PEGS Boston Summit

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for WLN: T6NJ CVQ? Find Soft Gelatin used in WLN: T6NJ CVQ to address drug delivery challenges on PharmaCompass.

WLN: T6NJ CVQ

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

21 API Suppliers

9 USDMF

3 CEP/COS

3 EU WC

2 KDMF

4 NDC API

12 Listed Suppliers

DEVELOPMENTS

18 Drugs in Development

FINISHED DOSAGE FORMULATIONS

100 FDF Dossiers

60 FDA Orange Book

16 Europe

1 Canada

2 South Africa

21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

3 Evonik

13 Rochem International Inc

23 SPI Pharma

2 Pharm-RX Chemical

6 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

20 Kirsch Pharma

1 Panvo Organics

1 Cerata Pharmaceuticals LLP

17 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

11 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

36 BASF

1 Bioplus Life Sciences

5 Cassava Pharma

4 CD Formulation

2 Clariant

15 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

3 Gloria Interchem

9 Ideal Cures

4 Ingredion Pharma Solutions

2 JJ Chemicals

22 Kerry

3 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

19 Microlex e.U

1 Nanjing Bold Chemical

2 Neelkanth MineChem

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

3 Pharmatrans-Sanaq

11 Pluviaendo

3 Prachin Pharmachem

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

35 Roquette

17 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

TABLET, EXTENDED RELEASE;ORAL - 1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 750MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons